Mannkind reported $1.36B in Market Capitalization for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acceleron Pharma XLRN:US $ 7.62B 606.02M
Adamas Pharmaceuticals ADMS:US 239.75M 41.19M
Adma Biologics ADMA:US $ 205.1M 10.57M
Biocryst Pharmaceuticals BCRX:US $ 2.81B 1B
Biodelivery Sciences International BDSI:US $ 352.73M 38.5M
BioSpecifics Technologies BSTC:US 38.8M 6.21M
Chemocentryx CCXI:US $ 933.95M 2.64B
Dicerna Pharmaceuticals DRNA:US $ 2.87B 918.39M
Dynavax Technologies DVAX:US $ 1.13B 15.39M
Eli Lilly And LLY:US $ 220.12B 40.96B
Flexion Therapeutics FLXN:US $ 411.02M 35.8M
Halozyme Therapeutics HALO:US $ 6.47B 491.5M
Immunogen IMGN:US $ 1.32B 300.21M
Insmed INSM:US $ 3.22B 293.47M
JAZZ PHA JAZZ:US 10.83B 1.57B
Karyopharm Therapeutics KPTI:US $ 774.96M 14.69M
Kindred Biosciences KIN:US $ 415.16M 192.96M
Macrogenics MGNX:US $ 1.62B 176.65M
Mannkind MNKD:US $ 1.36B 384.05M
Merk MRK:US $ 196918.18M 1780.24M
Minerva Neurosciences NERV:US $ 99.11M 25.63M
Novavax NVAX:US $ 15.73B 2.34B
Novo Nordisk A Fs NVO:US 148.5B 25.62B
Peregrine Pharmaceuticals PPHM:US $ 1.57B 458.25M
Pfizer PFE:US $ 219205.69M 17108.81M
Sanofi SAN:FP 111.4B 5.33B
Xencor XNCR:US $ 2.01B 489.02M